Shayan Mohammadmoradi: Excited to Share New Insights Into Platelet α-Granule Integrity and Aortic Aneurysms at ISTH 2026
Shayan Mohammadmoradi, Vascular Biology and Platelet Function Scientist at University of Kentucky, CEO at Moradi Enterprise, shared on X:
”The countdown to ISTH 2026 in Paris is on!
Only a few weeks left, and I am excited to present our work on ‘Platelet α-Granule Integrity and Aortic Aneurysms’ during the session on Platelet Roles in Thrombosis, Inflammation, and Disease Progression.
For early-career scientists attending the ISTH conference, I understand that this large event can be overwhelming.
Choosing sessions, networking, and maximizing your time can be challenging.
Please feel free to reach out or come say hello.
I would be happy to help you prioritize sessions, approach networking, or build a manageable schedule using the app!
I look forward to connecting with colleagues, friends, and new faces in Paris.”
Stay updated with Hemostasis Today.
-
Aug 7, 2026, 16:26Shayan Mohammadmoradi: Excited to Co-Chair the 2028 Hemostasis Gordon Research Seminar
-
Aug 7, 2026, 16:04Ayuka King-Percival: Understanding Platelet Aggregation Testing
-
Aug 7, 2026, 15:59Nita Radhakrishnan։ New Evidence-Based Guidelines for Transfusion-Dependent Thalassemia
-
Aug 7, 2026, 15:54Seema Dawood: Why the Peripheral Blood Smear Still Matters in the Age of Automation?
-
Aug 7, 2026, 15:42Mohammed Elmourtada Abdulgayoom։ Caplacizumab-Enabled Treatment of iTTP Without Plasma Exchange
-
Aug 7, 2026, 15:40Renata Evertz: THUNDER Study Sets a New Benchmark in Stroke Thrombectomy
-
Aug 7, 2026, 15:23Ashley Brown: An Incredible Week at the Hemostasis GRC
-
Aug 7, 2026, 15:04Danique Steeghs: Developing a Chip-Sized ADAMTS13 Activity Assay for TTP Point-of-Care Testing
-
Aug 7, 2026, 15:02Mohd Laraib: The Importance of Multidisciplinary Collaboration in the Management of CAPS